For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Publishing research using ab6814? Please let us know so that we can cite the reference in this datasheet.
ab6814 has been referenced in 4 publications.
- Okal A et al. Re-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model. Gene Ther : (2014).
- Reaz S et al. A single mutant, A276S of p53, turns the switch to apoptosis. Mol Pharm 10:1350-9 (2013).
- Dixon AS et al. Improved coiled-coil design enhances interaction with Bcr-Abl and induces apoptosis. Mol Pharm 9:187-95 (2012).
- Dixon AS et al. Disruption of bcr-abl coiled coil oligomerization by design. J Biol Chem 286:27751-60 (2011).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"